Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Drepadom - Establishment of Home Care Services and Hospitalizations for Sickle Cell Disease Patients As Standard Care Since the Covid-19 Pandemic

Yanís Pelinski, Cindy Mescam, Christian Kassasseya, Gonzalo De Luna, Henri Guillet, Clara Noizat, Sylvain Lejeune, Suella Martino, Dora Bachir, Françoise Driss, Amna Jebali, Anne-Laure Pham Hung D'Alexandry D'Orengiani, Nicolas Lemonier, France Pirenne, Anoosha Habibi, Pablo Bartolucci

Blood (2021) 138 (Supplement 1): 916.

https://doi.org/10.1182/blood-2021-147740

Published: 2021

Journal Articles

Drepadom - Home Care Services and Hospitalizations for Sickle Cell Disease Patients during the Covid-19 Pandemic

Gonzalo De Luna, Nicolas Lemonier, MD, Alexis Aidan, MD, Lea Bontemps, MD, Manuel Hautefaye, MD, Hadrien Diakonoff, MD, Cecile Aubrun, Anne-Laure Pham Hung D'Alexandry D'Orengiani, PhD, Dora Bachir, MD, Françoise Driss, MD, Amna Jebali, MD, Anoosha Habibi, MD PhD, Pablo Bartolucci, MD PhD

Blood (2020) 136 (Supplement 1): 12.

https://doi.org/10.1182/blood-2020-142796

Published: 2020

Journal Articles

Predictive Factors for Survival in Sickle Cell Disease: A Cohort Study Using Etendard Data

Laurent Savale, MD PhD, Gylna Loko, MD, François Lionnet, Bernard Maitre, Anoosha Habibi, Jocelyn Inamo, Dora Bachir, MD, Françoise Driss, Vincent Audard, MDPhD, Etienne Audureau, Marc Humbert, Gerald Simonneau, Frédéric Galactéros, MDPhD, Florence Parent, Pablo Bartolucci, MD PhD

Blood (2018) 132 (Supplement 1): 7.

https://doi.org/10.1182/blood-2018-99-113767

Published: 2018

Journal Articles

Adverse effect of hydroxyurea on spermatogenesis in patients with sickle cell anemia after 6 months of treatment

Isabelle Berthaut, Dora Bachir, Salma Kotti, Céline Chalas, Katia Stankovic, Florence Eustache, Célia Ravel, Anoosha Habibi, Sylvie Brailly-Tabard, Laurence Lévy-Dutel, Alexandre Bleibtreu, Tabassome Simon, Frédéric Galactéros, François Lionnet, Jacqueline Mandelbaum

Blood (2017) 130 (21): 2354–2356.

https://doi.org/10.1182/blood-2017-03-771857

Published: 2017

Journal Articles

Biological Parameters Predictive Of Percent Dense Red Blood Cell Decrease Under Hydroxyurea Therapy

Marie Georgine Rakotoson, PhD student, Gaetana Di Liberto, PhD, Anoosha Habibi, MD, Christine Fauroux, Clinical Research Associate, Sanam Khorgami, Master Student, Dora Bachir, MD, France Noizat-Pirenne, MD-PhD, Frederic Galacteros, MD PhD, Pablo Bartolucci, MD-PhD

Blood (2013) 122 (21): 990.

https://doi.org/10.1182/blood.V122.21.990.990

Published: 2013

Journal Articles

Prospective Comparison of Sperm Parameters in SCD Adult Patients Before and after a 6 Months Treatment with hydroxyurea (HU)

Dora Bachir, MD, Francois Lionnet, Justine Gellen Dautremer, Katia Stankovic, Anoosha Habibi, Pablo Bartolucci, MD, PhD, Céline Chalas, Isabelle Berthaut, Florence Eustache, Célia Ravel, Jean Marie Kuntsman, Robert Girot, MD, Tabassome Simon, Jacqueline Mandelbaum, Frederic Galacteros, MD PhD

Blood (2012) 120 (21): 242.

https://doi.org/10.1182/blood.V120.21.242.242

Published: 2012

Journal Articles

Decreased sickle red blood cell adhesion to laminin by hydroxyurea is associated with inhibition of Lu/BCAM protein phosphorylation

Pablo Bartolucci, Vicky Chaar, Julien Picot, Dora Bachir, Anoosha Habibi, Christine Fauroux, Frédéric Galactéros, Yves Colin, Caroline Le Van Kim, Wassim El Nemer

Blood (2010) 116 (12): 2152–2159.

https://doi.org/10.1182/blood-2009-12-257444

Published: 2010

Journal Articles

Oral Chelator Deferiprone in Adult with Sickle Cell Disease.

Ruben Nzouakou, MD, Anoosha Habibi, MD, Ketty Lee, Alain Luciani, Jean-François Deux, Frederic Galacteros, Dora Bachir, MD

Blood (2009) 114 (22): 4615.

https://doi.org/10.1182/blood.V114.22.4615.4615

Published: 2009

Journal Articles

Prospective Multicentric Survey On Pulmonary Hypertension (PH) in Adults with Sickle Cell Disease.

Dora Bachir, MD, Florence Parent, Laila Hajji, Jocelyn Inamo, Gylna Loko, Francois Lionnet, Françoise Driss, Laurent Savale, Bernard Maitre, Robert Girot, Pr, Gerald Simonneau, Frederic Galacteros

Blood (2009) 114 (22): 572.

https://doi.org/10.1182/blood.V114.22.572.572

Published: 2009

Journal Articles

A randomized, controlled clinical trial of ketoprofen for sickle-cell disease vaso-occlusive crises in adults

Pablo Bartolucci, Tony El Murr, Françoise Roudot-Thoraval, Anoosha Habibi, Aline Santin, Bertrand Renaud, Violaine Noël, Marc Michel, Dora Bachir, Frédéric Galactéros, Bertrand Godeau

Blood (2009) 114 (18): 3742–3747.

https://doi.org/10.1182/blood-2009-06-227330

Published: 2009

Journal Articles

Delayed Hemolytic Transfusion Reaction in Sickle Cell Disease Patients: Evidence of An Emerging Syndrome with Suicidal Erythrocyte Death

France Noizat-Pirenne, MD, PhD, Philippe Chadebech, PhD, Anoosha Habibi, MD, Dora Bachir, MD, Ruben Nzouakou, MD, Frederic Galacteros, MD, PhD, Philippe Bierling, MD, PhD

Blood (2008) 112 (11): 3037.

https://doi.org/10.1182/blood.V112.11.3037.3037

Published: 2008

Journal Articles

Successful Administration of Rituximab To Prevent Recurrence of Delayed Haemolytic Transfusion Reaction Developed in a Sickle Cell Disease Patient.

France Noizat-Pirenne, MD, PhD, Philippe Chadebech, PhD, Marc Michel, MD, Dora Bachir, MD, Frederic Galacteros, MD, PhD, Philippe Bierling, MD, PhD

Blood (2007) 110 (11): 2904.

https://doi.org/10.1182/blood.V110.11.2904.2904

Published: 2007

Journal Articles

Phlebotomy and Bolus Subcutaneous Deferoxamine in Algerian Patients with Thalassemia Major or Intermedia or Sickle Cell Disease Treated with Hydroxyurea.

Mohamed Bradai, MD, Dora Bachir, MD, Mariane De Montalembert, MD

Blood (2007) 110 (11): 3812.

https://doi.org/10.1182/blood.V110.11.3812.3812

Published: 2007

Journal Articles

Socio-Economic Impact of Infused Iron Chelation Therapy in France: ISOSFER Study Results.

Catherine Brun-Strang, Dora Bachir, Mariane De Montalembert, Isabelle Thuret

Blood (2006) 108 (11): 3354.

https://doi.org/10.1182/blood.V108.11.3354.3354

Published: 2006

Journal Articles

Psychological Outcome after Hematopoietic Cell Transplantation for Sickle Cell Disease.

Blood (2005) 106 (11): 2021.

https://doi.org/10.1182/blood.V106.11.2021.2021

Published: 2005

Journal Articles

A Phase 1 Pharmacokinetics (PK) Study of Hydroxyurea (HU) 1,000 mg Coated Breakable Tablets and 500 mg Capsules in Pediatric and Adult Patients with Sickle Cell Disease (SCD).

Mariane De Montalembert, MD, Dora Bachir, MD, Anne Hulin, MD, Linda Gimeno, Agnes Mogenet, MD, Jean-Louis Bresson, MD, Isabelle Macquin-Mavier, MD, Alain Astier, MD, Frederic Galacteros, MD

Blood (2005) 106 (11): 3194.

https://doi.org/10.1182/blood.V106.11.3194.3194

Published: 2005

Journal Articles

A Severe Case of Delayed Haemolytic Transfusion Reaction in a Sickle Cell Disease Patient: Immuno-Haematological Study, Cytokine Transcripts and Lymphocyte Subsets Analysis.

France Noizat-Pirenne, MD, PhD, Helene Ansart-Pirenne, MD, PhD, Anne Plonquet, MD, PhD, Philippe Chadebech, PhD, Anoosha Habibi, MD, Dora Bachir, MD, Frederic Galacteros, MD, PhD, Philippe Bierling, MD, PhD

Blood (2005) 106 (11): 954.

https://doi.org/10.1182/blood.V106.11.954.954

Published: 2005

Journal Articles

Treatment with rhEPO Decreases the Need for Transfusion in Patients with βThalassemia.

Dora Bachir, MD, Anoosha Habibi, MD, Serge Pissard, MD, Zohra Ourabah, MD, Frederic Galacteros, MD-PhD

Blood (2004) 104 (11): 3778.

https://doi.org/10.1182/blood.V104.11.3778.3778

Published: 2004

Journal Articles

Rare RHCE phenotypes in black individuals of Afro-Caribbean origin: identification and transfusion safety

France Noizat-Pirenne, Ketty Lee, Pierre-Yves Le Pennec, Philippe Simon, Philippe Kazup, Dora Bachir, Anne-Marie Rouzaud, Michèle Roussel, Geneviève Juszczak, Cècile Ménanteau, Philippe Rouger, Rami Kotb, Jean-Pierre Cartron, Hélène Ansart-Pirenne

Blood (2002) 100 (12): 4223–4231.

https://doi.org/10.1182/blood-2002-01-0229

Published: 2002

Journal Articles

The nonexpression of CD36 on reticulocytes and mature red blood cells does not modify the clinical course of patients with sickle cell anemia

Ketty Lee, Pierre Gane, Françoise Roudot-Thoraval, Bertand Godeau, Dora Bachir, Françoise Bernaudin, Jean-Pierre Cartron, Frédéric Galactéros, Philippe Bierling

Blood (2001) 98 (4): 966–971.

https://doi.org/10.1182/blood.V98.4.966

Published: 2001

NARROW

Drepadom - Establishment of Home Care Services and Hospitalizations for Sickle Cell Disease Patients As Standard Care Since the Covid-19 Pandemic

Drepadom - Home Care Services and Hospitalizations for Sickle Cell Disease Patients during the Covid-19 Pandemic

Predictive Factors for Survival in Sickle Cell Disease: A Cohort Study Using Etendard Data

Adverse effect of hydroxyurea on spermatogenesis in patients with sickle cell anemia after 6 months of treatment

Biological Parameters Predictive Of Percent Dense Red Blood Cell Decrease Under Hydroxyurea Therapy

Prospective Comparison of Sperm Parameters in SCD Adult Patients Before and after a 6 Months Treatment with hydroxyurea (HU)

Decreased sickle red blood cell adhesion to laminin by hydroxyurea is associated with inhibition of Lu/BCAM protein phosphorylation

Oral Chelator Deferiprone in Adult with Sickle Cell Disease.

Prospective Multicentric Survey On Pulmonary Hypertension (PH) in Adults with Sickle Cell Disease.

A randomized, controlled clinical trial of ketoprofen for sickle-cell disease vaso-occlusive crises in adults

Delayed Hemolytic Transfusion Reaction in Sickle Cell Disease Patients: Evidence of An Emerging Syndrome with Suicidal Erythrocyte Death

Successful Administration of Rituximab To Prevent Recurrence of Delayed Haemolytic Transfusion Reaction Developed in a Sickle Cell Disease Patient.

Phlebotomy and Bolus Subcutaneous Deferoxamine in Algerian Patients with Thalassemia Major or Intermedia or Sickle Cell Disease Treated with Hydroxyurea.

Socio-Economic Impact of Infused Iron Chelation Therapy in France: ISOSFER Study Results.

Psychological Outcome after Hematopoietic Cell Transplantation for Sickle Cell Disease.

A Phase 1 Pharmacokinetics (PK) Study of Hydroxyurea (HU) 1,000 mg Coated Breakable Tablets and 500 mg Capsules in Pediatric and Adult Patients with Sickle Cell Disease (SCD).

A Severe Case of Delayed Haemolytic Transfusion Reaction in a Sickle Cell Disease Patient: Immuno-Haematological Study, Cytokine Transcripts and Lymphocyte Subsets Analysis.

Treatment with rhEPO Decreases the Need for Transfusion in Patients with βThalassemia.

Rare RHCE phenotypes in black individuals of Afro-Caribbean origin: identification and transfusion safety

The nonexpression of CD36 on reticulocytes and mature red blood cells does not modify the clinical course of patients with sickle cell anemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only